Quick Answer
Alto Neuroscience, Inc. reported Research And Development Expense of $45.62 million for the year ending 2025.
- Alto Neuroscience, Inc. showed a decrease of -2.9% in Research And Development Expense from 2024 to 2025.
- This data is from Alto Neuroscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Alto Neuroscience, Inc.'s Research And Development Expense has grown by 50.6%.
- Historical annual values: Fiscal year 2025: $45.62 million | Fiscal year 2024: $47.00 million | Fiscal year 2023: $30.29 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: